Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Insulin Pricing Probe Clouds Prospects for Novo Nordisk, Others

Mar 17 2017

• By Brenda Sandburg

insulin hormone vials-single use syringe_1200x675

Related Content

Spring Break: Novo's US Head Resigns After Rough Winter

Mar 01 2017

Diabetes Rebate Model Challenged On Morality Grounds In Class Action Suit

Jan 31 2017

Generic Industry Hit With Avalanche Of Price Fixing Suits

Feb 22 2017

Janssen's Drug Pricing Report Emphasizes Value Of Rebates

Mar 01 2017

Lilly’s Insulin Discounts Target High-Deductible Insurance Gaps

Dec 13 2016

Winter Is Coming: What Can Novo Nordisk Do Next After Stock Fall?

Dec 08 2016

Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors

Sep 14 2016

Pharma Deals With The DOJ

Sep 14 2016

Related Companies

Novo Nordisk A/S

Sanofi

Eli Lilly and Company

Merck & Co., Inc.

Express Scripts Holding Company

CVS Health Corp.

UnitedHealth Group

Merck & Co., Inc.

Pfizer Inc.

Johnson & Johnson

Vyera Pharmaceuticals, LLC

Bausch Health Companies Inc.

Viatris Inc.

Lonza Group AG

Allergan plc

AbbVie Inc.

Additional Topics

Policy Legal Issues BioPharmaceutical

More from Legal & IP

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window